JPH10508872A - 活性酸素阻害剤の制御送達を用いる癒着の低減 - Google Patents
活性酸素阻害剤の制御送達を用いる癒着の低減Info
- Publication number
- JPH10508872A JPH10508872A JP8529500A JP52950096A JPH10508872A JP H10508872 A JPH10508872 A JP H10508872A JP 8529500 A JP8529500 A JP 8529500A JP 52950096 A JP52950096 A JP 52950096A JP H10508872 A JPH10508872 A JP H10508872A
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- sod
- composition
- adhesions
- hydrogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.組織部位における細胞増殖を阻害する組成物であって、該組織部位で重合バ リアを形成するために重合し得る物質、ならびに活性酸素種の阻害剤、不活性塩 と該阻害剤の複合体、および有機分子と該阻害剤との複合体からなる群から選択 される、有効量の1つまたはそれ以上の化合物を含み、ここで該阻害剤がカタラ ーゼではない、組成物。 2.薬学的に受容可能なキャリアをさらに含む、請求項1に記載の組成物。 3.活性酸素種の阻害剤以外の生物学的に活性な化合物をさらに含む、請求項1 に記載の組成物。 4.前記阻害剤が、ポリマーに放出可能に結合される、請求項1に記載の組成物 。 5.前記阻害剤が、リポソーム、マイクロ粒子、またはマイクロカプセルにカプ セル化される、請求項1に記載の組成物。 6.前記阻害剤が、インタクトなまたは粉末化したゲル中に存在する、請求項1 に記載の組成物。 7.重合したとき、前記物質がヒドロゲルを形成する、請求項1に記載の組成物 。 8.重合したとき、前記物質がインビボで生分解性である、請求項1に記載の組 成物。 9.前記物質が、光重合性である、請求項1に記載の組成物。 10.前記阻害剤が、スーパーオキシドジスムターゼ、アロプリノール、ベラパ ミル、およびそれらの組み合わせからなる群から選択される、請求項1に記載の 組成物。 11.前記阻害剤が、スーパーオキシドジスムターゼである、請求項10に記載 の組成物。 12.患者の組織部位における細胞増殖と関連した医学的条件を防止または緩和 する方法であって、該組織部位で重合バリア形成するように重合し得る物質、な らびに活性酸素種の阻害剤、該阻害剤と不活性塩との複合体、および該阻害剤と 有機分子との複合体からなる群から選択された1つまたはそれ以上の有効量の化 合物を含む組成物を、その処置を必要とする患者に投与する工程を包含する、方 法。 13.前記組成物が、薬学的に受容可能なキャリアをさらに含む、請求項12に 記載の方法。 14.前記組成物が、活性酸素種の阻害剤以外の生物学的に活性な化合物をさら に含む、請求項12に記載の方法。 15.前記阻害剤が、放出可能にポリマーに結合する、請求項12に記載の方法 。 16.前記阻害剤が、リポソーム、マイクロ粒子、またはマイクロカプセル中に カプセル化される、請求項12に記載の方法。 17.前記阻害剤が、インタクトなまたは粉末化したゲル中に存在する、請求項 12に記載の方法。 18.重合したとき、前記物質がヒドロゲルを形成する、請求項12に記載の方 法。 19.重合したとき、前記物質がインビボで生分解性である、請求項12に記載 の方法。 20.前記物質が、光重合性である、請求項12に記載の方法。 21.前記阻害剤が、スーパーオキシドジスムターゼ、アロプリノール、ベラパ ミル、カタラーゼ、およびそれらの組み合わせからなる群から選択される、請求 項12に記載の方法。 22.前記阻害剤が、スーパーオキシドジスムターゼである、請求項12に記載 の方法。 23.前記医学的条件が、手術後癒着、再狭窄、ケロイド瘢痕化、肥大性瘢痕化 、肥大性管閉塞、良性前立腺肥大、および子宮内膜症からなる群から選択される 、請求項12に記載の方法。 24.組織部位での細胞増殖と関連した医学的条件を処置することにおける使用 のための薬物を調製するための、請求項12〜23のいずれかに記載の組成物の 使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US410,219 | 1989-09-21 | ||
US41021995A | 1995-03-24 | 1995-03-24 | |
PCT/US1996/003813 WO1996029987A1 (en) | 1995-03-24 | 1996-03-20 | Reduction of adhesions using controlled delivery of active oxygen inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH10508872A true JPH10508872A (ja) | 1998-09-02 |
JP3145409B2 JP3145409B2 (ja) | 2001-03-12 |
Family
ID=23623783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52950096A Expired - Lifetime JP3145409B2 (ja) | 1995-03-24 | 1996-03-20 | 活性酸素阻害剤の制御送達を用いる癒着の低減 |
Country Status (8)
Country | Link |
---|---|
US (2) | US5785993A (ja) |
EP (1) | EP0814774B1 (ja) |
JP (1) | JP3145409B2 (ja) |
AT (1) | ATE306903T1 (ja) |
AU (1) | AU704222B2 (ja) |
CA (1) | CA2215317C (ja) |
DE (1) | DE69635301T2 (ja) |
WO (1) | WO1996029987A1 (ja) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU704222B2 (en) * | 1995-03-24 | 1999-04-15 | Genzyme Corporation | Reduction of adhesions using controlled delivery of active oxygen inhibitors |
US5899917A (en) * | 1997-03-12 | 1999-05-04 | Cardiosynopsis, Inc. | Method for forming a stent in situ |
US6123667A (en) | 1997-03-20 | 2000-09-26 | Focal, Inc. | Retracting tissue using photoadhering adhesive |
EP0887076A3 (en) * | 1997-05-07 | 1999-03-31 | Saturnus A.G. | Adhesion prevention and an endoscopic insufflation system therefor |
WO1999024038A1 (en) | 1997-11-07 | 1999-05-20 | Johns Hopkins University | Methods for treatment of disorders of cardiac contractility |
ES2297934T3 (es) * | 1998-08-03 | 2008-05-01 | Ronald E. Wheeler | Formula prostatica. |
US6627663B2 (en) | 1998-08-03 | 2003-09-30 | W. Jerry Easterling | Noninvasive method for treating hemangiomas through transdermal delivery of calcium channel blocker agents and medicament for use in such method |
US6525100B1 (en) | 1998-08-03 | 2003-02-25 | W. Jerry Easterling | Composition and method for treating peyronie's disease and related fibrotic tissue disorders |
US6031005A (en) * | 1998-08-03 | 2000-02-29 | Easterling; W. Jerry | Composition and method for treating Peyronie's disease and related connective tissue disorders |
US20080114092A1 (en) * | 1998-12-04 | 2008-05-15 | Incept Llc | Adhesion barriers applicable by minimally invasive surgery and methods of use thereof |
SK8562002A3 (en) | 1999-12-23 | 2003-10-07 | Pfizer Prod Inc | Pharmaceutical compositions providing enhanced drug concentrations |
CA2404157A1 (en) * | 2000-03-28 | 2001-10-04 | Robert J. Delorenzo | Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death |
FI20010898A0 (fi) * | 2001-04-30 | 2001-04-30 | Ylae Herttuala Seppo | Ekstrasellulaarinen superoksididismutaasi (EC-SOD) geeniterapia restenoosoin ehkäisemiseksi |
JP2006503605A (ja) * | 2002-04-30 | 2006-02-02 | フイット バイオテク オーワイジェイ ピーエルシー | 医療装置 |
CN100490900C (zh) * | 2002-08-20 | 2009-05-27 | 精密技术公司 | 骨生长诱导材料的携带和输送用组合物以及生产和应用该组合物的方法 |
US20040153027A1 (en) | 2002-10-28 | 2004-08-05 | Mantell Robert R. | Dual-capacity insufflator tube |
US7654975B2 (en) | 2003-04-24 | 2010-02-02 | Northgate Technologies, Inc. | Mixed-gas insufflation system |
WO2005034726A2 (en) * | 2003-09-23 | 2005-04-21 | Ortho Therapeutics, Llc | Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
US7955616B2 (en) * | 2003-09-23 | 2011-06-07 | Orthocon, Inc. | Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
WO2005035035A1 (en) | 2003-10-07 | 2005-04-21 | Northgate Technologies Inc. | System and method for delivering a substance to a body cavity |
US20050208095A1 (en) * | 2003-11-20 | 2005-09-22 | Angiotech International Ag | Polymer compositions and methods for their use |
US7332179B2 (en) * | 2003-12-12 | 2008-02-19 | Kimberly-Clark Worldwide, Inc. | Tissue products comprising a cleansing composition |
US20050244480A1 (en) * | 2004-04-30 | 2005-11-03 | Kimberly-Clark Worldwide, Inc. | Pre-wipes for improving anal cleansing |
US7642395B2 (en) * | 2004-12-28 | 2010-01-05 | Kimberly-Clark Worldwide, Inc. | Composition and wipe for reducing viscosity of viscoelastic bodily fluids |
US20060140899A1 (en) * | 2004-12-28 | 2006-06-29 | Kimberly-Clark Worldwide, Inc. | Skin cleansing system comprising an anti-adherent formulation and a cationic compound |
US9119901B2 (en) | 2005-04-28 | 2015-09-01 | Warsaw Orthopedic, Inc. | Surface treatments for promoting selective tissue attachment to medical impants |
US8414907B2 (en) | 2005-04-28 | 2013-04-09 | Warsaw Orthopedic, Inc. | Coatings on medical implants to guide soft tissue healing |
EP1906992A1 (fr) * | 2005-06-28 | 2008-04-09 | Life Science Investments Limited | Utilisation d' un melange de superoxyde dismutase et de catalase pour le traitement des lesions d origine inflammatoire de la peau |
JP2009523118A (ja) * | 2005-11-14 | 2009-06-18 | ユニバーシティー、オブ、デラウェア | 新規ハイドロゲルおよびそれらの使用 |
US7706852B2 (en) | 2006-01-30 | 2010-04-27 | Nellcor Puritan Bennett Llc | System and method for detection of unstable oxygen saturation |
JP2009545417A (ja) | 2006-08-04 | 2009-12-24 | ノースゲート テクノロジーズ インコーポレイテッド | 体内へアクセスするための留置ポート |
US20080241270A1 (en) * | 2007-03-30 | 2008-10-02 | Neal Robert A | Fluid composition for inhibiting surgical adhesion formation and related method of production |
EP2498764B1 (en) | 2009-11-09 | 2017-09-06 | Spotlight Technology Partners LLC | Fragmented hydrogels |
JP5864429B2 (ja) | 2009-11-09 | 2016-02-17 | スポットライト テクノロジー パートナーズ エルエルシーSpotlight Technology Partners Llc | 架橋ヒドロゲル組成物、ヒドロゲル組成物の形成方法、及びキット |
US9555054B2 (en) | 2012-11-21 | 2017-01-31 | University Of Louisville Research Foundation, Inc. | Compositions and methods for reducing oxidative damage |
US9572595B1 (en) | 2014-03-05 | 2017-02-21 | Northgate Technologies Inc. | In-dwelling port for access into a body |
WO2016130478A1 (en) | 2015-02-09 | 2016-08-18 | University Of Louisville Research Foundation, Inc. | Ophthalmic compositions and methods for reducing oxidative damage to an eye lens |
US10590257B2 (en) | 2016-09-26 | 2020-03-17 | The Board Of Trustees Of The Leland Stanford Junior University | Biomimetic, moldable, self-assembled cellulose silica-based trimeric hydrogels and their use as viscosity modifying carriers in industrial applications |
CN106468668B (zh) * | 2016-09-28 | 2019-03-12 | 北京凯视佳光电设备有限公司 | 工业相机圆柱检测方法 |
US11969526B2 (en) | 2017-04-03 | 2024-04-30 | The Board Of Trustees Of The Leland Stanford Junior University | Adhesion prevention with shear-thinning polymeric hydrogels |
US11911504B2 (en) | 2018-02-02 | 2024-02-27 | Galen Therapeutics Llc | Apparatus and method for protecting neurons and reducing inflammation and scarring |
US11975123B2 (en) | 2018-04-02 | 2024-05-07 | The Board Of Trustees Of The Leland Stanford Junior University | Adhesion prevention with shear-thinning polymeric hydrogels |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3784585A (en) * | 1971-10-21 | 1974-01-08 | American Cyanamid Co | Water-degradable resins containing recurring,contiguous,polymerized glycolide units and process for preparing same |
US4371519A (en) * | 1972-06-05 | 1983-02-01 | Hettinger Jr William P | Methods of treating cellular tissue |
US4897308A (en) * | 1975-06-30 | 1990-01-30 | L'oreal | Compositions comprising aqueous dispersions of lipid spheres |
US4563349A (en) * | 1980-07-30 | 1986-01-07 | Takeda Chemical Industries, Ltd. | Superoxide dismutase, its immobilized form, and their production and use |
DE3378250D1 (en) * | 1982-04-22 | 1988-11-24 | Ici Plc | Continuous release formulations |
US5286763A (en) * | 1983-03-22 | 1994-02-15 | Massachusetts Institute Of Technology | Bioerodible polymers for drug delivery in bone |
JPS6014861A (ja) * | 1983-07-05 | 1985-01-25 | 株式会社日本メデイカル・サプライ | 癒着防止材 |
DE3486452T2 (de) * | 1983-10-03 | 1997-11-06 | Chiron Corp., Emeryville, Calif. | Superoxiddismutase und deren Expression in Mikroorganismen |
US4511478A (en) * | 1983-11-10 | 1985-04-16 | Genetic Systems Corporation | Polymerizable compounds and methods for preparing synthetic polymers that integrally contain polypeptides |
US4873292A (en) * | 1984-12-28 | 1989-10-10 | Research Development Corporation Of Japan | Antithrombogenic synthetic polymer and process for its preparation |
US4760051A (en) * | 1985-01-24 | 1988-07-26 | Pickart Loren R | Use of GHL-Cu as a wound-healing and anti-inflammatory agent |
CS254355B1 (en) * | 1985-04-10 | 1988-01-15 | Vladimir Saudek | Soluble and biodegradatable copolymeres activated for bond of biologicaly active substances |
JPH084504B2 (ja) * | 1985-04-26 | 1996-01-24 | 味の素株式会社 | 安定化ス−パ−オキサイドジスムタ−ゼ |
IN166447B (ja) * | 1985-11-27 | 1990-05-12 | Ethicon Inc | |
US4889722A (en) * | 1985-12-16 | 1989-12-26 | Ethicon, Inc. | Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
US4806621A (en) * | 1986-01-21 | 1989-02-21 | Massachusetts Institute Of Technology | Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article |
US4976959A (en) * | 1986-05-12 | 1990-12-11 | Burroughs Wellcome Co. | T-PA and SOD in limiting tissue damage |
US4741872A (en) * | 1986-05-16 | 1988-05-03 | The University Of Kentucky Research Foundation | Preparation of biodegradable microspheres useful as carriers for macromolecules |
US5160745A (en) * | 1986-05-16 | 1992-11-03 | The University Of Kentucky Research Foundation | Biodegradable microspheres as a carrier for macromolecules |
IT1198449B (it) * | 1986-10-13 | 1988-12-21 | F I D I Farmaceutici Italiani | Esteri di alcoli polivalenti di acido ialuronico |
US5547988B1 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid |
US5260204A (en) * | 1987-03-14 | 1993-11-09 | Boehringer Ingelheim International Gmbh | Human manganese superoxide dismutase (hMn-SOD) |
US5227405A (en) * | 1987-03-31 | 1993-07-13 | Duke University | Superoxide dismutase mimic |
US5223538A (en) * | 1987-03-31 | 1993-06-29 | Duke University | Superoxide dismutase mimic |
ATE120647T1 (de) * | 1987-05-28 | 1995-04-15 | Hiroshi Maeda | Superoxid-dismutase-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel. |
IL82834A (en) * | 1987-06-09 | 1990-11-05 | Yissum Res Dev Co | Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom |
HU209955B (en) * | 1987-07-01 | 1994-12-28 | Genentech Inc | Process for producing pharmaceutical compositions containing tissue- -plasminogen-activator of poor solubility for inhibiting production and regeneration of deformities |
US5080891A (en) * | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
US4804691A (en) * | 1987-08-28 | 1989-02-14 | Richards Medical Company | Method for making a biodegradable adhesive for soft living tissue |
US5364622A (en) * | 1987-12-04 | 1994-11-15 | Dr. Karl Thomae Gmbh | Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel |
US4888413A (en) * | 1988-01-11 | 1989-12-19 | Domb Abraham J | Poly(propylene glycol fumarate) compositions for biomedical applications |
US4898734A (en) * | 1988-02-29 | 1990-02-06 | Massachusetts Institute Of Technology | Polymer composite for controlled release or membrane formation |
US5057494A (en) * | 1988-08-03 | 1991-10-15 | Ethicon, Inc. | Method for preventing tissue damage after an ischemic episode |
US5328471A (en) * | 1990-02-26 | 1994-07-12 | Endoluminal Therapeutics, Inc. | Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens |
US5213580A (en) * | 1988-08-24 | 1993-05-25 | Endoluminal Therapeutics, Inc. | Biodegradable polymeric endoluminal sealing process |
US4925677A (en) * | 1988-08-31 | 1990-05-15 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US4911926A (en) * | 1988-11-16 | 1990-03-27 | Mediventures Inc. | Method and composition for reducing postsurgical adhesions |
US5135751A (en) * | 1988-11-16 | 1992-08-04 | Mediventures Incorporated | Composition for reducing postsurgical adhesions |
US5126141A (en) * | 1988-11-16 | 1992-06-30 | Mediventures Incorporated | Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides |
CA2004740A1 (en) * | 1988-12-07 | 1990-06-07 | Cary Linsky | Low molecular weight heparin, heparinoid and hexuronyl hexosaminoglycan sulfate containing adhesion prevention barrier and process |
US5108755A (en) * | 1989-04-27 | 1992-04-28 | Sri International | Biodegradable composites for internal medical use |
IL90193A (en) * | 1989-05-04 | 1993-02-21 | Biomedical Polymers Int | Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same |
US4994277A (en) * | 1989-10-31 | 1991-02-19 | Pfizer Hospital Products Group, Inc. | Use of xanthan gum for preventing adhesions |
US5175235A (en) * | 1990-06-04 | 1992-12-29 | Nova Pharmaceutical Corporation | Branched polyanhydrides |
EP0589871B1 (en) * | 1990-02-13 | 2000-04-26 | Ethicon, Inc. | Peritoneal induced medicaments |
US5292516A (en) * | 1990-05-01 | 1994-03-08 | Mediventures, Inc. | Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers |
US5219564A (en) * | 1990-07-06 | 1993-06-15 | Enzon, Inc. | Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
US5143731A (en) * | 1990-08-07 | 1992-09-01 | Mediventures Incorporated | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
US5217966A (en) * | 1990-09-13 | 1993-06-08 | The Regents Of The University Of California | Synthetic drug molecules that mimic metalloenzymes |
US5410016A (en) * | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5529914A (en) * | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
US5288502A (en) * | 1991-10-16 | 1994-02-22 | The University Of Texas System | Preparation and uses of multi-phase microspheres |
AU673160B2 (en) * | 1992-02-28 | 1996-10-31 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5384333A (en) * | 1992-03-17 | 1995-01-24 | University Of Miami | Biodegradable injectable drug delivery polymer |
AU3972893A (en) * | 1992-04-03 | 1993-11-08 | Baylor College Of Medicine | Gene therapy using the intestine |
ATE173171T1 (de) * | 1993-03-23 | 1998-11-15 | Focal Inc | Gerät und methode für den lokalen auftrag von polymermaterial auf gewebe |
WO1994024962A1 (en) * | 1993-04-28 | 1994-11-10 | Focal, Inc. | Apparatus and methods for intraluminal photothermoforming |
US5519035A (en) * | 1993-07-02 | 1996-05-21 | Cornell Research Foundation, Inc. | Treatment of stroke or in anticipation of the occurrence of brain ischemia |
EP0705298B1 (en) * | 1993-12-01 | 2002-03-27 | Bioartificial Gel Technologies Inc. | Albumin based hydrogel |
US5419917A (en) * | 1994-02-14 | 1995-05-30 | Andrx Pharmaceuticals, Inc. | Controlled release hydrogel formulation |
JP3492787B2 (ja) * | 1994-04-15 | 2004-02-03 | 信越化学工業株式会社 | 固形製剤のコーティング用水性エマルジョンの濃縮方法 |
IL109539A0 (en) * | 1994-05-03 | 1994-08-26 | Yissum Res Dev Co | Substained-release pharmaceutical system for the delivery of antioxidants |
US5478837A (en) | 1994-06-07 | 1995-12-26 | University Of Southern California | Use of quinacrine in preventing adhesion formation |
US5562594A (en) * | 1994-06-10 | 1996-10-08 | Duke University | Shielded mini-applicator system for radioactive source treatment of cancer of the uterine cervix |
AU704222B2 (en) * | 1995-03-24 | 1999-04-15 | Genzyme Corporation | Reduction of adhesions using controlled delivery of active oxygen inhibitors |
US5527864A (en) * | 1995-08-08 | 1996-06-18 | Suggs; Laura J. | Poly(propylene fumarate-co-ethylene oxide) |
-
1996
- 1996-03-20 AU AU52575/96A patent/AU704222B2/en not_active Expired
- 1996-03-20 DE DE69635301T patent/DE69635301T2/de not_active Expired - Lifetime
- 1996-03-20 EP EP96908878A patent/EP0814774B1/en not_active Expired - Lifetime
- 1996-03-20 WO PCT/US1996/003813 patent/WO1996029987A1/en active IP Right Grant
- 1996-03-20 CA CA002215317A patent/CA2215317C/en not_active Expired - Lifetime
- 1996-03-20 JP JP52950096A patent/JP3145409B2/ja not_active Expired - Lifetime
- 1996-03-20 AT AT96908878T patent/ATE306903T1/de not_active IP Right Cessation
- 1996-07-29 US US08/689,139 patent/US5785993A/en not_active Expired - Lifetime
-
1998
- 1998-07-27 US US09/123,137 patent/US6780427B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0814774B1 (en) | 2005-10-19 |
EP0814774A1 (en) | 1998-01-07 |
CA2215317C (en) | 2002-07-23 |
DE69635301D1 (de) | 2006-03-02 |
JP3145409B2 (ja) | 2001-03-12 |
ATE306903T1 (de) | 2005-11-15 |
US20010046503A1 (en) | 2001-11-29 |
US5785993A (en) | 1998-07-28 |
AU704222B2 (en) | 1999-04-15 |
WO1996029987A1 (en) | 1996-10-03 |
AU5257596A (en) | 1996-10-16 |
US6780427B2 (en) | 2004-08-24 |
CA2215317A1 (en) | 1996-10-03 |
DE69635301T2 (de) | 2006-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3145409B2 (ja) | 活性酸素阻害剤の制御送達を用いる癒着の低減 | |
US8512729B2 (en) | Fragmented polymeric compositions and methods for their use | |
EP0732915B1 (en) | Local delivery of fibrinolysis enhancing agents | |
Hill-West et al. | Local release of fibrinolytic agents for adhesion prevention | |
Chowdhury et al. | Adhesion prevention with ancrod released via a tissue-adherent hydrogel | |
EP1107791B1 (en) | Hydrogel compositions for the controlled release administration of growth factors | |
US8357378B2 (en) | Fragmented polymeric compositions and methods for their use | |
US8603511B2 (en) | Fragmented polymeric compositions and methods for their use | |
US20080187568A1 (en) | Polymerization with precipitation of proteins for elution in physiological solution | |
CA2583561A1 (en) | Biocompatible protein particles, particle devices and methods thereof | |
KR101452041B1 (ko) | 유착방지재 및 유착방지 방법 | |
US6461640B1 (en) | Local delivery of fibrinolysis enhancing agents | |
EP0297860B1 (en) | Method and therapeutic compositions for the prevention of fibrin deposition or adhesions | |
WO2008132233A1 (en) | Composition, methods and kits for prevention of adhesion | |
EA046077B1 (ru) | Регулирование кинетики высвобождения в гидрогелях |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090105 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100105 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110105 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120105 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130105 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130105 Year of fee payment: 12 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |